• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Unspecified (PubMed=9802058).
  

CLPUB00738
Karin Charlotte Nitiss;
Oncogenic changes and induction of differentiation in pediatric astrocytic cell lines.
Thesis PhD (1997); University of Southern California Los Angeles; Los Angeles; USA

PubMed=9802058
Christina R. McPake, David M. Tillman, Catherine A. Poquette, E. Olusegen George, Janet A. Houghton, Linda C. Harris;
Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.
Oncol. Res. 10:235-244(1998)

PubMed=10402232; DOI=10.3892/ijo.15.2.237
Taraneh R. Sharif, Mohammed Sharif;
Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples.
Int. J. Oncol. 15:237-243(1999)

PubMed=10933967; DOI=10.1006/mthe.2000.0064
Cynthia A. Pawlik, Rekha V. Iyengar, Erik J. Krull, Stephen E. Mason, Ruchi Khanna, Linda C. Harris, Philip M. Potter, Mary K. Danks, Sylvie M. Guichard;
Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11.
Mol. Ther. 1:457-463(2000)

PubMed=11306486
Rekha V. Iyengar, Cynthia A. Pawlik, Erik J. Krull, Doris A. Phelps, Rebecca A. Burger, Linda C. Harris, Philip M. Potter, Mary K. Danks;
Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.
Cancer Res. 61:3045-3052(2001)